FDA: Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format

This guidance is intended to assist applicants with developing the PATIENT COUNSELING INFORMATION section. The recommendations in this guidance are intended to help ensure that this section of labeling is clear, useful, informative, and to the extent possible, consistent in content and format.